Actualités

Motley Fool1d agobullish

Is Kailera Therapeutics a Buy After Its Sizzling IPO?

There's a new challenger to the more established players in the weight-loss drug space.

Investor's Business Daily5d agoneutral

Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In Obesity

Analysts initiated covered Tuesday of IPO stock Kailera Therapeutics, a potential competitor to Lilly and Novo in obesity treatment.

Investor's Business Daily

Bloomberg11d agobearish

Eli Lilly Sells $9 Billion of Bonds to Fund Acquisitions

(Bloomberg) -- Eli Lilly & Co. sold $9 billion of investment-grade bonds Wednesday — the company’s biggest-ever issuance — as it looks to finance an acquisition spree. Most Read from BloombergUS Has Opened a Passage Through Hormuz, Central Command SaysUS Says Offensive Phase of Iran War Over as Ship Hit in StraitAnthropic Unveils AI Agents to Field Financial Services TasksDOJ Plans Intervention in Trump Supreme Court Carroll AppealTrump Pauses Plan to Guide Ships While Seeking Iran DealThe drugm

LLY

MT Newswires11d agobearish

Update: Market Chatter: Eli Lilly Plans to Sell About $8 Billion of Bonds to Fund Acquisitions

(Updates with the company's response in the fourth paragraph.) Eli Lilly (LLY) is looking to rais

LLY